• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Century Therapeutics, Inc. - Common Stock (NQ:IPSC)

1.960 -0.100 (-4.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Century Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
August 12, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
July 09, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
June 08, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer ↗
May 31, 2026
This biotechnology firm leverages machine learning to design novel protein therapeutics targeting unmet medical needs. 
Via The Motley Fool
Topics Initial Public Offering
Century Therapeutics (NASDAQ:IPSC) Reports Narrower Loss, Extended Cash Runway to 2029 ↗
March 12, 2026
Via Chartmill
News headline image
Century Therapeutics Reports First Quarter Financial Results and Business Updates
May 13, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
April 30, 2026
CNTY-813 is an iPSC-derived islet cell replacement therapy engineered with Allo-Evasion™ 5.0 for patients with type 1 diabetes; on track for IND submission in 4Q 2026 
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
March 12, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics to Participate in Upcoming Investor Conferences in March
February 25, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire
Here are the top movers in Thursday's session. ↗
January 08, 2026
Via Chartmill
These stocks are gapping in today's session ↗
January 08, 2026
Via Chartmill
News headline image
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
January 08, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
December 09, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
November 13, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
October 14, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
August 22, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Reports Flat Loss in Fiscal Q2 ↗
August 14, 2025
Via The Motley Fool
News headline image
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Monday's after hours session: top gainers and losers ↗
July 07, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
May 28, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
April 16, 2025
 
Via Benzinga
News headline image
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
April 15, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
March 28, 2025
 
Via Benzinga
News headline image
Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday ↗
March 24, 2025
 
Via Benzinga
News headline image
Demystifying Century Therapeutics: Insights From 4 Analyst Reviews ↗
March 21, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
March 19, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap